This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

USANA And See Eye To Eye On Visionex®

SALT LAKE CITY, Nov. 14, 2012 /PRNewswire/ -- USANA's vision of excellence is crystal clear. USANA Health Sciences, Inc. (NYSE: USNA), a global nutritional company, announced today that its advanced eye health supplement, Visionex®, has been evaluated and approved by, LLC, a leading provider of independent product test results.


In a recent study on eye health supplements, determined that USANA's Visionex® contains at least 100 percent of the claimed amounts of lutein and claimed amounts of zeaxanthin listed on the label; satisfies California's Proposition 65 levels for lead contamination; adheres to recommended United States Pharmacopeia (USP) disintegration parameters; and meets Food and Drug Administration (FDA) labeling requirements.

"We know our products contain exactly what is listed on the label, but it's critical to have third-party confirmation and approval," says Dan Macuga, USANA chief communications officer. "We're proud of how well our products have performed in independent testing from reputable third-party organizations such as"

This review tested similar eye health products from various nutritional supplement manufacturers to determine whether they in fact contained the right amounts of lutein and zeaxanthin on their labels. The review can be found on the company's website at

In light of new FDA warnings against potentially unsafe supplements available on the market, testing helps consumers and healthcare professionals make better decisions and more informed recommendations when it comes to supplements.

"There is a lot of research and development that go into each of our products. Lutein and zeaxanthin are crucial for eye health—that's why they are essential ingredients in Visionex," states Dr. Carsten Smidt, USANA vice president of research and development. "We use the highest quality ingredients possible, and we have pharmaceutical quality protocols in place that guarantee potency and purity."

Since 1999, has tested more than 3,200 products, 350 different brands and nearly every type of popular supplement in order to help consumers and healthcare professionals identify the best quality health and nutrition products. is also the only third-party verification group that freely publishes its testing methods and quality criteria/standards.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,084.49 +33.74 0.20%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,830.47 +19.6820 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs